Clinical–histopathological correlation of breast cancer in patients treated at Bertha Calderón Roque Hospital
Authors
DOI:
https://doi.org/10.37980/im.journal.revcog.es.20252728Keywords:
Breast cancer, Clinical staging, HistopathologyAbstract
Objective: To evaluate the correlation between the clinical stage and the histopathological staging of breast cancer in patients treated at the Oncology Department of the Bertha Calderón Roque Hospital during the period from January to December 2023. Material and method: A retrospective, correlational, and analytical study. The sample consisted of 83 cases of early-stage breast cancer that met the inclusion criteria. Clinical history, clinical findings, and histopathological results were recorded. Results: The average age at diagnosis was 57 years. Various clinical characteristics were observed, including variability in tumor size, laterality, and the presence of palpable lymph nodes. Mastectomy was the most frequent surgical intervention (54.2%), while the most common initial treatment was neoadjuvant chemotherapy (59.0%). Histopathological analysis showed a predominance of grade 2 infiltrating ductal carcinomas and a significant association between the clinical stage and the histopathological outcome. Conclusions: A statistically significant association was identified between the clinical stage and the histopathological staging of breast cancer. In addition, a direct correlation was observed between tumor size, the presence of axillary lymph node metastases, and a worse prognosis for the patient.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Infomedic Intl.Derechos autoriales y de reproducibilidad. La Revista RevCog es un ente académico, sin fines de lucro, que forma parte de la Sociedad Centroamericana de Ginecología y Obstetricia. Sus publicaciones son de tipo ACCESO GRATUITO y PERMANENTE de su contenido para uso individual y académico, sin restricción. Los derechos autoriales de cada artículo son retenidos por sus autores. Al Publicar en la Revista, el autor otorga Licencia permanente, exclusiva, e irrevocable a la Sociedad para la edición del manuscrito, y otorga a la empresa editorial, Infomedic International Licencia de uso de distribución, indexación y comercial exclusiva, permanente e irrevocable de su contenido y para la generación de productos y servicios derivados del mismo.




